Skip to main content
SCONRES 88 110th Congress Senate Health Drug approvals Estrogen Physicians Women Women's health

A concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.

Introduced: June 10, 2008 Introduced by: Cornyn, John Republican · Texas See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 10, 2008
Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5455-5456)
Jun 10, 2008
Introduced in Senate
 Plain-English summary Congressional Research Service

Calls for the Food and Drug Administration (FDA) to reverse its policy that aims to eliminate patient access to compounded medications containing estriol prescribed by physicians unless it holds a public comment period on the issue and can document evidence of adverse events and other safety issues to justify such policy.

What's happening now June 10, 2008

Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5455-5456)

 Committees of jurisdiction 1